Follow
Matthew R. Hight
Matthew R. Hight
Unknown affiliation
Verified email at vanderbilt.edu
Title
Cited by
Cited by
Year
The next chapter in MOF pillaring strategies: trigonal heterofunctional ligands to access targeted high-connected three dimensional nets, isoreticular platforms
JF Eubank, L Wojtas, MR Hight, T Bousquet, VC Kravtsov, M Eddaoudi
Journal of the American Chemical Society 133 (44), 17532-17535, 2011
1762011
On demand: the singular rht net, an ideal blueprint for the construction of a metal–organic framework (MOF) platform
JF Eubank, F Nouar, R Luebke, AJ Cairns, L Wojtas, M Alkordi, ...
Angewandte Chemie-International Edition 51 (40), 10099, 2012
1422012
Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2, 5-dimethoxybenzyl)-2-phenoxyaniline
JR Buck, ET McKinley, MR Hight, A Fu, D Tang, RA Smith, MN Tantawy, ...
Journal of Nuclear Medicine 52 (1), 107-114, 2011
732011
Quantitative preclinical imaging of TSPO expression in glioma using N, N-diethyl-2-(2-(4-(2-18F-fluoroethoxy) phenyl)-5, 7-dimethylpyrazolo [1, 5-a] pyrimidin-3-yl) acetamide
D Tang, MR Hight, ET McKinley, A Fu, JR Buck, RA Smith, MN Tantawy, ...
Journal of Nuclear Medicine 53 (2), 287-294, 2012
712012
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer
M Hassanein, MR Hight, JR Buck, MN Tantawy, ML Nickels, ...
Molecular imaging and biology 18, 18-23, 2016
562016
Synthesis and structure–activity relationships of 5, 6, 7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging
D Tang, ET McKinley, MR Hight, MI Uddin, JM Harp, A Fu, ML Nickels, ...
Journal of medicinal chemistry 56 (8), 3429-3433, 2013
542013
Mutant KRAS exosomes alter the metabolic state of recipient colonic epithelial cells
Q Zhang, DK Jeppesen, JN Higginbotham, MD Beckler, EJ Poulin, ...
Cellular and Molecular Gastroenterology and Hepatology 5 (4), 627-629. e6, 2018
382018
A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells
MR Hight, YY Cheung, ML Nickels, ES Dawson, P Zhao, S Saleh, ...
Clinical Cancer Research 20 (8), 2126-2135, 2014
362014
Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo
ML Schulte, MR Hight, GD Ayers, Q Liu, Y Shyr, MK Washington, ...
Molecular imaging and biology 19, 421-428, 2017
242017
Multispectral fluorescence imaging to assess pH in biological specimens
MR Hight, DD Nolting, ET McKinley, AD Lander, SK Wyatt, M Gonyea, ...
Journal of biomedical optics 16 (1), 016007-016007-7, 2011
232011
Microwave-assisted organic synthesis of a high-affinity pyrazolo-pyrimidinyl TSPO ligand
D Tang, JR Buck, MR Hight, HC Manning
Tetrahedron letters 51 (35), 4595-4598, 2010
232010
TSPO-targeted PET and optical probes for the detection and localization of premalignant and malignant pancreatic lesions
AS Cohen, J Li, MR Hight, E McKinley, A Fu, A Payne, Y Liu, D Zhang, ...
Clinical Cancer Research 26 (22), 5914-5925, 2020
92020
N-[18F]-Fluoroacetylcrizotinib: A potentially potent and selective PET tracer for molecular imaging of non-small cell lung cancer
JR Buck, S Saleh, T Claus, C Lovly, MR Hight, ML Nickels, MN Tantawy, ...
Bioorganic & medicinal chemistry letters 30 (16), 127257, 2020
42020
Compound, composition, and method for detecting caspase activity and/or apoptosis
HC Manning, MR Hight
US Patent 10,294,271, 2019
12019
Glutamine PET to Predict Response to Dual Pharmacological Inhibition of BRAFV600E and PI3K/mTOR Pathway Activity in vivo.
M Schulte, M Hight, G Ayers, F Revetta, MK Washington, M Nickels, ...
Journal of Nuclear Medicine 57 (supplement 2), 447-447, 2016
2016
CCDC 1408291: Experimental Crystal Structure Determination: catena-[(mu-5-(4H-1, 2, 4-triazol-4-yl) isophthalato)-copper unknown solvate]
JF Eubank, L Wojtas, MR Hight, T Bousquet, VC Kravtsov, M Eddaoudi
Cambridge Crystallographic Data Centre, 2015
2015
PET imaging diagnostics of mitochondrial homeostasis in precision cancer medicine
MR Hight
2014
Molecular imaging of glutaminolysis as a tool for evaluating therapeutic response in preclinical models of colorectal cancer
MR Hight, ML Schulte, S Saleh, GD Ayers, FL Revetta, MK Washington, ...
Cancer Research 74 (19_Supplement), 2058-2058, 2014
2014
CCDC 866715: Experimental Crystal Structure Determination: catena-((mu~ 12~-tris (4-(5'-ethynyl-1, 1': 3''. 1''-terphenyl-4, 4''-dicarboxylic acid) phenyl) amine)-tri-aqua-tri …
JF Eubank, F Nouar, R Luebke, A Cairns, L Wojtas, M Al Kordi, ...
Cambridge Crystallographic Data Centre, 2013
2013
CCDC 866713: Experimental Crystal Structure Determination: catena-(bis (mu~ 12~-5, 5', 5''-(1, 3, 5-benzenetriyltris (methyleneoxy))-tris (1, 3-benzenedicarboxylato))-hexa-aqua …
JF Eubank, F Nouar, R Luebke, A Cairns, L Wojtas, M Al Kordi, ...
Cambridge Crystallographic Data Centre, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20